Ribavirin Plasma Concentration Measurements in Patients With Hepatitis C: Early Ribavirin Concentrations Predict Steady-State Concentrations

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

(2010) J. Morello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

(2008) Michael W. Fried et al.   HEPATOLOGY

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C

(2008) Véronique Loustaud-Ratti et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

(2008) D. Aguilar Marucco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C

(2008) J. Morello et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV

(2008) Florence Nicot et al.   JOURNAL OF MEDICAL VIROLOGY